Abstract: An agent for treating and/or preventing diseases due to a constrictive vascular lesion, which comprises, as an active ingredient, a hydroxamic acid derivative represented by formula (I): 1

Abstract: A magnet section is constructed by installing a coil (2) on a yoke (1), and an armature (3) is placed facing the attracting surface of this magnet section. Indentations and projections are formed to confer the characteristics of both an opposing type electromagnet and a plunger type electromagnet on the magnetic path portion that faces yoke (1) and armature (3). By doing this, the attractive force characteristics will be uniform, and the operating speed and the holding position of the armature can be set as desired by adjusting the magnetization. Thus, the force of impact can be lessened by deceleration control of the armature, and the impact noise can be reduced. In a further aspect, a thin, single sheet annular, noise-damping waveform spring (6) is attached to the outer edge of the attracting surface of the magnet's yoke (1) or armature (3).

Abstract: The invention relates to a method for improving inner ear microcirculation, which comprises administering an effective amount of a dihydropyridine compound of the general formula: ##STR1## wherein R.sup.1 is a nitrophenyl group; and R.sup.2, R.sup.3 and R.sup.4 each is a lower alkyl group, or a pharmaceutically acceptable salt thereof to a human or animal.

Abstract: An elevator brake is provided with a redundant means to release the brake to allow an elevator cab to move when a primary releasing means, such as a coil, does not release when desired. When the coil is deenergized or defective, an auxiliary coil is used to release the brake and enable the cab to move.